Company profile
Street Capital Inc.
OTC: REZNF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
17DFH 15DQ —GM 18SS 31
v0.1 · 45/100 weight · provisional
↑ workforce scale, growth stability · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$111.5k
Employees
72
as of 2026-08-28
Market cap
$56.1k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$111.5k-155.8k CAD2025
Operating income-$120.5k-168.4k CAD2025
Total assets$57.4k78.6k CAD2025
Liabilities$284.8k390.3k CAD2025
Equity-$227.4k-311.7k CAD2025
Revenue trend
FY2017 – FY2025 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Street Capital Inc.’s revenue?
Street Capital Inc. booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Wesana Health Holdings Inc.——Pathfinder Cell Therapy, Inc.——Biome Grow Inc.——Manhattan Scientifics, Inc.——Mera Pharmaceuticals, Inc.——Hero Technologies Inc.——Key facts
CEOChris Savoie
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: REZNF
Employees72
IPO date2021-09-24
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.